Evidence map›Paper›PMID 31905240›Full record

ArticleBlood advances2020

Low VWF levels in children and lack of association with bleeding in children undergoing tonsillectomy.

Joan Cox Gill, Stephen F Conley, Victoria P Johnson, Pamela A Christopherson, Sandra L Haberichter, Christina D Diaz, Tatyana C Strong, Jian Zhang, Pippa Simpson, Thomas C Abshire and 2 more

Abstract read
In one paragraph

Article in Blood advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. (Un) Diagnosing von Willebrand disease.Hematology. American Society of Hematology. Education Program · 2025
    Review
  2. Article
  3. Beyond the count: platelet dysfunction profile in pediatric trauma patients.Research and practice in thrombosis and haemostasis · 2025
    Article
  4. Article
  5. Low von Willebrand factor-unraveling an enigma wrapped in a conundrum.Journal of thrombosis and haemostasis : JTH · 2024
    Review
  6. Article
  7. Article
  8. Diagnostic pitfalls and conundrums in type 1 von Willebrand disease.Hematology. American Society of Hematology. Education Program · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Von Willebrand Disease: Current Status of Diagnosis and Management.Hematology/oncology clinics of North America · 2021
    Review
  13. Review
  14. Observational
  15. Article
  16. Assessing the Impact of the 2021 VWD Guidelines on the Diagnosis/Management of Low VWF Patients.Haemophilia : the official journal of the World Federation of Hemophilia
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Joan Cox GillDivision of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Stephen F ConleyDepartment of Otolaryngology and Communication Sciences.
Victoria P JohnsonVersiti Blood Research Institute, Milwaukee, WI; and.
Pamela A ChristophersonVersiti Blood Research Institute, Milwaukee, WI; and.
Sandra L HaberichterDivision of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Christina D DiazDepartment of Anesthesia, and.
Tatyana C StrongDepartment of Anesthesia, and.
Jian ZhangDivision of Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Pippa SimpsonDivision of Quantitative Health Sciences, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Thomas C AbshireDivision of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Robert R MontgomeryDivision of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.
Veronica H FloodDivision of Hematology/Oncology, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI.

Funding

Zimmerman Program for the Molecular and Clinical Biology of VWDP01HL081588 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2005 to 2016
$19.3M
Zimmerman Program on the Biology of VWDP01HL144457 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2019 to 2023
$13.3M
Comparative Effectiveness in the Diagnosis of VWDR01HL112614 · NHLBI · VERSITI WISCONSIN, INC. · PI ABSHIRE, THOMAS CALVIN, MONTGOMERY, ROBERT R · 2013 to 2018
$4.1M
Molecular Interactions of FVIII and VWFR01HL139847 · NHLBI · VERSITI WISCONSIN, INC. · PI MONTGOMERY, ROBERT R · 2018 to 2021
$2.3M
Mechanism of Type 4 Collagen Interactions with Von Willebrand FactorR01HL126810 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI FLOOD, VERONICA H · 2016 to 2020
$1.9M
NHLBI NIH HHS P01 HL081588NHLBI NIH HHS P01 HL144457NHLBI NIH HHS R01 HL112614NHLBI NIH HHS R01 HL126810NHLBI NIH HHS R01 HL139847
6 · The paper itself

Abstract

von Willebrand disease is a common bleeding disorder, but diagnosis can be difficult in young children who have not had bleeding challenges. We sought to evaluate the correlation between bleeding and von Willebrand factor (VWF) levels in children undergoing surgical challenge with tonsillectomy. Children ages 0 to 18 undergoing tonsillectomy without a personal or family history of bleeding were enrolled prospectively following informed consent and institutional review board approval. VWF levels were obtained at the time of surgery. VWF antigen (VWF:Ag) and VWF activity (VWF:GPIbM) were tested via enzyme-linked immunosorbent assay. Bleeding score was calculated using the International Society of Hematology bleeding assessment tool (BAT). Surgical and postoperative bleeding were determined using questionnaires filled out by the surgeon and patient/family. A total of 1399 subjects were enrolled with evaluable data, with a median age of 5 years. The median VWF:Ag was 85 IU/dL and the median VWF:GPIbM was 100 U/dL. Median BAT for the entire population was 0, including those with postoperative bleeding. There was no difference in VWF level between those who experienced postoperative bleeding and those who did not, with median VWF:Ag 85 vs 85 (P = .89) and mean VWF:GPIbM 98 vs 100 (P = .5). Interestingly, there was a difference in VWF levels with age, with median VWF:Ag 81 for those younger than 3 years, 82 for those 3 to 6 years, 90 for those 7 to 10 years, and 100 for those 11 to 18 years. A similar trend was noted for VWF:GPIbM. Of the 2 to 6 year olds, 5% had VWF:Ag <50, which would meet criteria for low VWF, but only 1.8% had an abnormal BAT at study entry and only 2.5% bled after surgery. Only 1 subject with low VWF had an elevated postoperative BAT >2. These data suggest that low VWF levels do not correlate with bleeding in children undergoing tonsillectomy. In addition, VWF levels outside the adult normal range in young children may be more common than previously thought and do not necessarily predict surgical bleeding.

Indexed as

Tonsillectomyvon Willebrand DiseasesAdolescentAdultChildChild, PreschoolHemorrhageHumansInfantInfant, NewbornSurveys and Questionnairesvon Willebrand Factorvon Willebrand Factor

Identifiers

PMID31905240
PMCPMC6960478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.